Arvinas ARVN
NASDAQ ARVN
$9.35 +0.04 (+0.43%)
As of: Sep 4, 2026 · 2:27 PM EDT

Arvinas (ARVN) Capital Expenditures (2017 - 2026)

Arvinas (ARVN) posted quarterly Capital Expenditures of $1.3 million for Q1 2026, up 225.0% year-over-year from $400000.0 in Q1 2025, and up 192.86% quarter-over-quarter from -$1.4 million in Q4 2025.

Analysis

Arvinas (ARVN) Capital Expenditures (2017 - 2026) Analysis & Trends

Arvinas' Capital Expenditures history runs 10 years deep, the most recent figure standing at $1.3 million for Q1 2026.

  • In Q1 2026, Capital Expenditures rose 225.0% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.2 million (down 45.45% YoY), while the FY2025 annual figure was $300000.0, down 83.33% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $1.3 million, up from -$1.4 million in the prior quarter.
  • The five-year high for Capital Expenditures was $2.1 million in Q1 2022, with the low at -$1.6 million in Q2 2022.
  • The 5-year median for Capital Expenditures is $500000.0 (2023), against an average of $400000.0.
  • The sharpest annual moves came in 2023 and 2025: Capital Expenditures soared 650.0% in 2023, then slumped 566.67% in 2025.
  • Arvinas' Capital Expenditures stood at -$200000.0 in 2022, then soared by 150.0% to $100000.0 in 2023, then surged by 200.0% to $300000.0 in 2024, then plunged by 566.67% to -$1.4 million in 2025, then jumped by 192.86% to $1.3 million in 2026.
  • Business Quant data shows ARVN's Capital Expenditures at $1.3 million in Q1 2026, -$1.4 million in Q4 2025, and $100000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 2.29 Mn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 251.02 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 6.26 Mn
10 Arvinas 605.88 Mn 37.98 Mn - 200,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200,000.00
Mar 31, 2026 1.30 Mn
Dec 31, 2025 200,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 1.20 Mn
Mar 31, 2025 400,000.00
Dec 31, 2024 300,000.00
Sep 30, 2024 700,000.00
Jun 30, 2024 700,000.00
Mar 31, 2024 100,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 1.10 Mn
Jun 30, 2023 600,000.00
Mar 31, 2023 1.10 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 2.20 Mn
Jun 30, 2022 1.40 Mn
Mar 31, 2022 2.10 Mn
Dec 31, 2021 1.90 Mn
Sep 30, 2021 1.30 Mn